“PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY”. Voprosy Onkologii, vol. 66, no. 1, Jan. 2020, pp. 23-28, https://doi.org/10.37469/0507-3758-2020-66-1-23-28.